After Hours Summary: CE +14.4%, MAT +6.7%, CHKE +3.4%, PRO -17.9%, STRM -9.3%, AMD -9.0% following earnings/guidance
After Hours Gainers:
Companies trading higher in after hours in reaction to earnings: CE +14.4%, MAT +6.7%, CHKE +3.4%, SLB +2.5%, CYT +2.2%, MFLX +0.7%
Companies trading higher in after hours in reaction to news: TRXC +58.0% (announced completion of good laboratory practice studies using the SurgiBot system; co stated it remains on track to submit its FDA 510(k) filing in mid-2015), SSH +6.3% (announced that the FDA has reviewed co's submission regarding the COUNTER HF's U.S. pivotal study pause and requested minor protocol changes be submitted in order to receive approval to resume patient enrollment), GIG +3.7% (Fred H. Brenner disclosed 7.05% passive stake in 13G filing), SM +3.7% (announced that Q1 production is expected to be 16.8 MMBOE, or 186.4 MBOE/d; borrowing base maintained at $2.4 bln), ARCO +1.5% (announced that coffee sales at McDonald's (MCD) Brazil set a new 7-day record in early April, serving 66 mln liters between April 1 and April 7, up 34% from the same period a year ago), KALU +0.9% (announced the authorization of a $100 mln increase in its share repurchase authorization), HAL +0.7% (Reuters reporting co has engaged Bank of American and Deutsche Bank to assist with sale of assets worth up to $5 bln)
After Hours Losers:
Companies trading lower in after hours in reaction to earnings: PRO -17.9%, STRM -9.3%, AMD -9.0%, NOW -8.8%, MTW -3.5%, AXP -1.4%
Companies trading lower in after hours in reaction to news: DSCO -13.0% (co announced it has voluntarily ceased commercialization of SURFAXIN; announced restructuring involving workforce reduction by ~50%), WPCS -5.2% (following a Special Meeting the Board determined it was in the best interests of the Company to effect a reverse split of the issued and outstanding common stock at a ratio of 1-for-22), TC -4.5% (reported Q1 total concentrate production for Mount Milligan was 30.3 thousand dry tonnes, with 15.4 mln pounds of payable copper and 46.k ounces of payable gold), ASND -3.5% (disclosed that its collaboration partner, Sanofi (SNY) has decided to cease development of TransCon insulin